Your browser doesn't support javascript.
loading
An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML.
Sorror, Mohamed L; Gooley, Ted A; Storer, Barry E; Gerds, Aaron T; Sekeres, Mikkael A; Medeiros, Bruno C; Wang, Eunice S; Shami, Paul J; Adekola, Kehinde; Luger, Selina; Baer, Maria R; Rizzieri, David A; Wildes, Tanya M; Koprivnikar, Jamie; Smith, Julie; Garrison, Mitchell; Kojouri, Kiarash; Schuler, Tammy A; Leisenring, Wendy M; Onstad, Lynn E; Becker, Pamela S; McCune, Jeannine S; Lee, Stephanie J; Sandmaier, Brenda M; Appelbaum, Frederick R; Estey, Elihu H.
Affiliation
  • Sorror ML; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Gooley TA; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.
  • Storer BE; Clinical Statistics Program, Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Gerds AT; Department of Biostatistics, School of Public Health, University of Washington, Seattle, WA.
  • Sekeres MA; Clinical Statistics Program, Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Medeiros BC; Department of Biostatistics, School of Public Health, University of Washington, Seattle, WA.
  • Wang ES; Leukemia & Myeloid Disorders Program, Cleveland Clinic, Cleveland, OH.
  • Shami PJ; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.
  • Adekola K; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA.
  • Luger S; Roswell Park Comprehensive Cancer Center, Buffalo, NY.
  • Baer MR; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
  • Rizzieri DA; Division of Hematology Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL.
  • Wildes TM; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Koprivnikar J; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD.
  • Smith J; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC.
  • Garrison M; Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha NE.
  • Kojouri K; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.
  • Schuler TA; Confluence Health/Wenatchee Valley Hospital and Clinic, Wenatchee, WA.
  • Leisenring WM; Confluence Health/Wenatchee Valley Hospital and Clinic, Wenatchee, WA.
  • Onstad LE; Skagit Valley Hospital, Mount Vernon, WA.
  • Becker PS; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • McCune JS; Clinical Statistics Program, Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Lee SJ; Department of Biostatistics, School of Public Health, University of Washington, Seattle, WA.
  • Sandmaier BM; Clinical Statistics Program, Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Appelbaum FR; Division of Hematology/Oncology, University of California, Irvine, Irvine, CA.
  • Estey EH; Department of Population Sciences, City of Hope, Duarte, CA.
Blood ; 141(3): 295-308, 2023 01 19.
Article in En | MEDLINE | ID: mdl-36260765

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation Type of study: Clinical_trials / Observational_studies Aspects: Patient_preference Limits: Aged / Humans Language: En Journal: Blood Year: 2023 Document type: Article Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation Type of study: Clinical_trials / Observational_studies Aspects: Patient_preference Limits: Aged / Humans Language: En Journal: Blood Year: 2023 Document type: Article Country of publication: Estados Unidos